Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.takesolutions.com | |
Market Cap | 318.06 Cr. | |
Enterprise Value(EV) | 332.53 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -54.38 | Trailing Twelve Months Ending 2022-09 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2022-09 |
Industry PE | 27.33 | Trailing Twelve Months Ending 2022-09 |
Book Value / Share | 10.01 | Trailing Twelve Months Ending 2022-09 |
Price to Book Value | 2.15 | Calculated using Price: 21.55 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 14.79 Cr. | 147,934,000 Shares |
FaceValue | 1 | |
Company Profile | ||
The company delivers domain-intensive services in Life Sciences and Supply Chain Management. The company offers clients a unique combination of full service Clinical, Regulatory and Safety services with unique technology expertise. The Company's services span clinical trials to regulatory submissions to post-marketing strategy with insights derived through proprietary industry network forums. |
1 Day |
|
-0.92% |
1 Week |
|
-3.15% |
1 Month |
|
-9.64% |
3 Month |
|
-9.26% |
6 Month |
|
-12.04% |
1 Year |
|
-47.82% |
2 Year |
|
-60.57% |
5 Year |
|
-87.25% |
10 Year |
|
-19.59% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 13.88 | 16.08 | 21.61 | 19.05 | 14.37 | 12.61 | -0.71 | -33.78 | -13.84 | |
Return on Capital Employed (%) | 11.84 | 13.91 | 18.78 | 17.74 | 14.91 | 13.21 | 1.38 | -21.31 | -4.92 | |
Return on Assets (%) | 7.27 | 8.96 | 11.69 | 11.32 | 9.96 | 8.55 | -0.46 | -21.09 | -5.84 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 470 | 524 | 631 | 911 | 1,328 | 1,518 | 1,575 | 1,125 | 181 | 148 | |
Non Curr. Liab. | 82 | 26 | 99 | 81 | 89 | 80 | 219 | 178 | 33 | 15 | |
Curr. Liab. | 262 | 316 | 443 | 336 | 415 | 724 | 660 | 524 | 873 | 141 | |
Minority Int. | 48 | 56 | 40 | 42 | 8 | 9 | 10 | 0 | 0 | -1 | |
Equity & Liab. | 862 | 922 | 1,214 | 1,369 | 1,840 | 2,331 | 2,464 | 1,826 | 1,221 | 303 | |
Non Curr. Assets | 401 | 397 | 587 | 590 | 662 | 1,159 | 1,266 | 965 | 134 | 124 | |
Curr. Assets | 461 | 525 | 626 | 779 | 1,178 | 1,172 | 1,199 | 861 | 954 | 179 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 862 | 922 | 1,214 | 1,369 | 1,840 | 2,331 | 2,464 | 1,826 | 1,221 | 303 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
Net Sales | 816 | 730 | 1,030 | 1,345 | 1,587 | 2,039 | 2,213 | 774 | 655 | 351 | |
Other Income | 6 | 8 | 21 | 13 | 6 | 11 | 26 | 12 | 17 | 20 | |
Total Income | 822 | 739 | 1,051 | 1,357 | 1,594 | 2,050 | 2,239 | 786 | 672 | 372 | |
Total Expenditure | -668 | -620 | -866 | -1,082 | -1,281 | -1,656 | -2,044 | -847 | -648 | -428 | |
PBIDT | 153 | 118 | 185 | 275 | 313 | 394 | 195 | -61 | 24 | -57 | |
Interest | -14 | -13 | -15 | -23 | -21 | -25 | -41 | -37 | -29 | -14 | |
Depreciation | -77 | -20 | -25 | -87 | -104 | -154 | -167 | -115 | -80 | -40 | |
Taxation | -1 | -5 | -20 | -19 | -28 | -37 | 2 | -14 | -4 | -1 | |
Exceptional Items | -225 | ||||||||||
PAT | 62 | 80 | 125 | 146 | 160 | 178 | -11 | -452 | -89 | -111 | |
Minority Interest | -4 | -10 | -5 | -3 | 1 | -1 | -1 | -2 | 0 | 0 | |
Share Associate | |||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 58 | 70 | 120 | 143 | 160 | 177 | -12 | -452 | -782 | -804 | |
Adjusted EPS | 5 | 6 | 10 | 11 | 11 | 12 | -1 | -31 | -54 | -55 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 117 | 100 | 74 | 148 | 56 | 121 | 104 | 211 | 135 | 30 | |
Cash Fr. Inv. | -70 | -91 | -16 | -257 | -129 | -179 | -485 | -236 | -57 | -31 | |
Cash Fr. Finan. | -31 | -7 | -11 | 114 | 56 | 302 | 100 | 21 | -84 | -55 | |
Net Change | 16 | 2 | 46 | 5 | -17 | 244 | -281 | -4 | -6 | -56 | |
Cash & Cash Eqvt | 70 | 72 | 121 | 91 | 74 | 317 | 47 | 45 | 39 | 29 |
Mon, 23 Jan 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication Pursuant to Rule 6 of the Investor Education and Protection Fund Authority (Accounting Audit Transfer and Refund) Rules 2016 please find enclosed herewith copies of the Notice for transfer of all unpaid/unclaimed shares for the last seven (7) consecutive years to IEPF Authority published in newspapers namely Makkal Kural (Tamil) and Financial Express (English) dated January 21 2023 respectively.Kindly take the same on record and acknowledge. |
Thu, 12 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 We are enclosing herewith certificate dated January 3 2023 issued by Link Intime India Private Limited Registrar and Transfer Agent (RTA) of the Company confirming compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018. Please take note of the same. |
Fri, 30 Dec 2022
Closure of Trading Window Pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 as amended by SEBI (Prohibition of Insider Trading) (Amendment) Regulations 2018 and in accordance with the "Code of Conduct for Prohibition of Insider Trading (the Code) the Trading Window for dealing in the securities of the Company remains closed for the Designated Persons and their immediate relatives from January 1 2023 to till two trading days (both days inclusive) after the dissemination of the unaudited financial results of the Company for the quarter ending December 31 2022.The date of Board meeting for declaration of unaudited financial results of the Company for the quarter ending December 31 2022 will be notified and uploaded on the website of the Company. Designated Persons and their immediate relatives are prohibited to enter/ deal in any transaction involving sale or purchase of shares of TAKE Solutions Limited during the period of closure of Trading Window. Please take note of the same. |
Mon, 30 Jan 2023 |
|
|
|
|
|